Neovasc Stock Price

0.00 (0.0%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Neovasc Inc NVCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.90 08:43:25
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
0.9002 0.91 0.0098 - -
Trades Volume Avg Volume 52 Week Range
4 55 1,150,947 0.68 - 3.08
Last Trade Time Type Quantity Stock Price Currency
07:45:07 26 $ 0.90 USD

Neovasc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 60.75M 67.50M 67.42M $ 1.96M $ - -1.73 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Neovasc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NVCN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.92010.95470.8550.9030535826,652-0.0201-2.18%
1 Month0.861.130.8550.97719071,369,4400.044.65%
3 Months1.121.150.700.9150411,199,533-0.22-19.64%
6 Months0.982.600.701.643,622,742-0.08-8.16%
1 Year2.323.080.681.572,266,600-1.42-61.21%
3 Years4.5011.490.3722.462,659,442-3.60-80.0%
5 Years49.00334.000.37214.267,369,114-48.10-98.16%

Neovasc Description

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. Neovasc is developing the Tiara for the treatment of mitral valve disease.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.